Inspira Technologies Oxy B H N Ltd (IINN) Return on Equity ROE from the fourth quarter 2024 to fourth quarter 2022 and annually, average high and low, overall ranking from Dec 31 2024 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Inspira Technologies Oxy B H N Ltd  (NASDAQ: IINN)

Inspira Technologies Oxy B H N Ltd's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Inspira Technologies Oxy B H N Ltd in the fourth quarter 2024?
Inspira Technologies Oxy B H N Ltd achieved a return on average equity (ROE) of 361.06 % in its fourth quarter 2024, this is above IINN's average return on equity of -154.98%.
Inspira Technologies Oxy B H N Ltd shareholder's equity over the 12 months ending in its fourth quarter 2024 are valued at $3 million

ROE has advanced compared to 0% in the third quarter 2024, due to net income growth.

Within the Medical Equipment & Supplies industry 195 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2024 from 0 to 22.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Equity Change -56.52 % -70.43 % -24.68 % -48.94 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 11 0 0 0 0
Return On Equity (TTM) 361.06 % 0 % 0 % 0 % 0 %
IINN's Total Ranking # 22 # 0 # 0 # 0 #
Equity (TTM) in Millions 2 1 4 4 5
Seq. Equity Change 81.77 % -70.43 % 0 % -19.11 % 23.62 %
Seq. Net Income Change - - - - -

Back to IINN Management Effectiveness >> IINN's 5 Years Annual ROE >> Compare IINN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 196
Sector # 870
Overall # 22

Return On Equity Statistics
High Average Low
255.74 %
-154.98 %
-569.09 %
(Dec 31 2024)   (Dec 31 2025)





IINN Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 2 4 6 14 24
Y / Y Equity Change -46.25 % -24.68 % -57.9 % -42.55 % -
Net Income in Millions -13 11 -11 -15 -17
Y / Y Net Income Change - - - - -
Return On Equity -569.09 % 255.74 % -196.69 % -109.87 % -72.46 %

Back to IINN Management Effectiveness >> IINN's 5 Years Annual ROE >> Compare IINN ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
IINN's' Return on Equity at Yahoo Finance
IINN's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for IINN's Competitors
Subscribers only: Roe for Inspira Technologies Oxy B H N Ltd's Suppliers
Subscribers only: Return On Equity for IINN's Customers




Companies with similar Return On Equity at Dec 31 2024, within Healthcare Sector ROE
Hca Healthcare Inc   674.13 %
Gridai Technologies Corp  597.06 %
Polypid Ltd  377.69 %
Organon and Co   298.70 %
Inspira Technologies Oxy B H N Ltd  255.74 %
Davita Inc   168.73 %
Longduoduo Co Ltd  167.17 %
Halozyme Therapeutics Inc   138.37 %
Tao Synergies Inc   96.43 %
3m Company  95.68 %
Biomx Inc  88.72 %
Adma Biologics Inc   85.68 %
Earth Science Tech Inc   85.13 %
Eli Lilly And Company  76.84 %
Tenet Healthcare Corp  76.52 %
Addex Therapeutics Ltd  75.10 %

Date modified: 2026-09-02T17:55:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.